Skip to main content Skip to main navigation menu Skip to site footer
Articles
Published: 2023-03-22

Assessment of anxiolytic-like effects of acute and chronic treatment of flurbiprofen in murine

Department of physiology, biochemistry and pharmacology, Faculty of Veterinary Medicine, University of Mosul, Mosul, Iraq
Department of physiology, biochemistry, and pharmacology, College of Veterinary Medicine, University of Mosul, Mosul, Iraq

Abstract

Background: Non-steroidal anti-inflammatory drugs are commonly used medications with atypical pharmacological effects. This aims to evaluate the anxiolytic-like effects of flurbiprofen in rodent models. 

Methods: In vivo experimental try was conducted from October 2022 to January 2023 at the college of veterinary medicine, university of Mosul, Iraq. The effect of flurbiprofen was assessed in mice exposed to the elevated plus maze (EPM), light-dark box test (LDT), and open-field test (OFT). Fifty male mice were divided into two groups of twenty-five, weighing 30–35 g, for acute and chronic treatment. Each group was subdivided into five subgroups: distilled water was administered to the control group; the positive control was injected with 10 mg/kg diazepam; and the flurbiprofen groups were administered orally at 10, 20, and 40 mg/kg. Each subgroup was subjected to EPM, LDT, and OFT one hour after administration. The second group was also subdivided like the first group. It was treated for 15 days constantly and subjected to anxiety tests on the 16th day.

Results: Acute treatment with 20 mg/kg flurbiprofen revealed an anxiolytic effect, with increased time spent in the open arm of the EPM test, increased time spent in the LDB test, and increased time spent in the central area in the OFT compared to the control group. Chronic administration of flurbiprofen was ineffective in producing an anxiolytic effect.

Conclusion: The low doses of flurbiprofen may eliminate the anxiety effect in experimental mice; however, the anti-anxiety effect does not appear significantly after repeated or chronic administration of flurbiprofen.



Downloads

Download data is not yet available.

References

  1. Li W, Zhao N, Yan X, et al. The prevalence of depressive and anxiety symptoms and their associations with quality of life among clinically stable older patients with psychiatric disorders during the COVID-19 pandemic. Transl Psychiatry. 2021;11(1):1-8. DOI: 10.1038/s41398-021-01196-y
  2. Steimer T. The biology of fear-and anxiety-related behaviors. Dialogues Clin Neurosci. 2002 Sep;4(3):231-49. doi: 10.31887/DCNS.2002.4.3/tsteimer.
  3. Hussein RM, Mohamed WR, Omar HA. A neuroprotective role of kaempferol against chlorpyrifos-induced oxidative stress and memory deficits in rats via GSK3β-Nrf2 signaling pathway. Pestic Biochem Physiol. 2018; 152:29-37. DOI: 10.1016/j.pestbp.2018.08.008
  4. Russo E, Leo A, Crupi R, et al. Everolimus improves memory and learning while worsening depressive and anxiety-like behavior in an animal model of depression. J Psychiatr Res. 2016; 78:1-10. DOI: 10.1016/j.jpsychires.2016.03.008
  5. Montgomery SA, Judge R. Treatment of depression with associated anxiety: comparisons of tricyclic antidepressants and selective serotonin reuptake inhibitors. Acta Psychiatr Scand. 2000;101:9-16. DOI: 10.1111/j.1600-0447.2000.tb10943.x
  6. Dunner DL, Ishiki D, Avery DH, Wilson LG, Hyde TS. Effect of alprazolam and diazepam on anxiety and panic attacks in panic disorder: a controlled study. J Clin Psychiatry. 1986 Sep;47(9):458-60. PMID: 2875064
  7. Hayes PE, Schulz SC. Beta-blockers in anxiety disorders. J Affect Disord. 1987;13(2):119-130. DOI: 10.1016/0165-0327(87)90017-6
  8. Mealy K, Ngeh N, Gillen P, Fitzpatrick G, Keane FB, Tanner A. Propranolol reduces the anxiety associated with day case surgery. Eur J surgery= Acta Chir. 1996;162(1):11-14. PMID: 8679756
  9. Bay-Richter C, Wegener G. Antidepressant effects of NSAIDs in rodent models of depression—A systematic review. Front Pharmacol. 2022;13. DOI: 10.3389/fphar.2022.909981
  10. Governa P, Cusi MG, Borgonetti V, et al. Beyond the biological effect of a chemically characterized poplar propolis: Antibacterial and antiviral activity and comparison with flurbiprofen in cytokines release by lps-stimulated human mononuclear cells. Biomedicines. 2019;7(4):73. DOI: 10.3390/biomedicines7040073
  11. Miyakawa T, Leiter LM, Gerber DJ, et al. Conditional calcineurin knockout mice exhibit multiple abnormal behaviors related to schizophrenia. Proc Natl Acad Sci. 2003;100(15):8987-8992. DOI: 10.1073/pnas.1432926100
  12. Hogg S. A review of the validity and variability of the elevated plus-maze as an animal model of anxiety. Pharmacol Biochem Behav. 1996;54(1):21-30. DOI: 10.1016/0091-3057(95)02126-4
  13. Bourin M, Hascoët M. The mouse light/dark box test. Eur J Pharmacol. 2003;463(1-3):55-65. DOI: 10.1016/s0014-2999(03)01274-3
  14. Takao K, Miyakawa T. Light/dark Transition Test for Mice. JoVE. 1. 2006 Nov 13;(1):104. DOI: 10.3791/104.
  15. Prut L, Belzung C. The open field as a paradigm to measure the effects of drugs on anxiety-like behaviors: a review. Eur J Pharmacol. 2003;463(1-3):3-33. DOI: 10.1016/s0014-2999(03)01272-x
  16. Salim S, Chugh G, Asghar M. Inflammation in anxiety. Adv Protein Chem Struct Biol. 2012; 88:1-25. DOI: 10.1016/B978-0-12-398314-5.00001-5
  17. Sulakhiya K, Keshavlal GP, Bezbaruah BB, et al. Lipopolysaccharide induced anxiety-and depressive-like behaviour in mice are prevented by chronic pre-treatment of esculetin. Neurosci Lett. 2016;611:106-111. DOI: 10.1016/j.neulet.2015.11.031
  18. Ballok DA, Ma X, Denburg JA, Arsenault L, Sakic B. Ibuprofen fails to prevent brain pathology in a model of neuropsychiatric lupus. J Rheumatol. 2006;33(11):2199-2213. PMCID: PMC1635783
  19. Mesripour A, Shahnooshi S, Hajhashemi V. Celecoxib, ibuprofen, and indomethacin alleviate depression-like behavior induced by interferon-alfa in mice. J Complement Integr Med. 2020;17(1). DOI: 10.1515/jcim-2019-0016
  20. Guevara C, Fernandez AC, Cardenas R, Suarez-Roca H. Reduction of spinal PGE2 concentrations prevents swim stress-induced thermal hyperalgesia. Neurosci Lett. 2015; 591:110-114. DOI: 10.1016/j.neulet.2015.02.035
  21. Alboni S, Benatti C, Capone G, Tascedda F, Brunello N. Neither all anti-inflammatory drugs nor all doses are effective in accelerating the antidepressant-like effect of fluoxetine in an animal model of depression. J Affect Disord. 2018; 235:124-128. DOI: 10.1016/j.jad.2018.04.063
  22. Blanchard DC, Griebel G, Blanchard RJ. Mouse defensive behaviors: pharmacological and behavioral assays for anxiety and panic. Neurosci Biobehav Rev. 2001;25(3):205-218. DOI: 10.1016/s0149-7634(01)00009-4
  23. Jamil A, Mahboob A, Ahmed T. Ibuprofen targets neuronal pentraxins expresion and improves cognitive function in mouse model of AlCl3‑induced neurotoxicity. Exp Ther Med. 2016;11(2):601-606. DOI: 10.3892/etm.2015.2928


How to Cite

1.
Naser AS, Alberifkani NM. Assessment of anxiolytic-like effects of acute and chronic treatment of flurbiprofen in murine . jidhealth [Internet]. 2023 Mar. 22 [cited 2024 Apr. 26];6(1):814-9. Available from: https://jidhealth.com/index.php/jidhealth/article/view/268